Protease inhibitors and indoleamines selectively inhibit cholinesterases in the histopathologic structures of Alzheimer disease.

Neurofibrillary tangles and amyloid plaques express acetylcholinesterase and butyrylcholinesterase activity in Alzheimer disease. We previously reported that traditional acetylcholinesterase inhibitors such as BW284C51, tacrine, and physostigmine were more potent inhibitors of the acetylcholinestera...

Descripció completa

Dades bibliogràfiques

Publicat a:	Proc Natl Acad Sci U S A
Autors principals:	Wright, C I, Guela, C, Mesulam, M M
Format:	Artigo
Idioma:	Inglês
Publicat:	National Academy of Sciences 1993
Matèries:	Research Article
Accés en línia:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC45728/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/8421706/ https://ncbi.nlm.nih.govhttps://doi.org/10.1073/pnas.90.2.683
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!